A detailed history of Rock Point Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rock Point Advisors, LLC holds 1,986 shares of MRK stock, worth $253,651. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,986
Previous 2,235 11.14%
Holding current value
$253,651
Previous $243,000 7.82%
% of portfolio
0.08%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $28,196 - $32,855
-249 Reduced 11.14%
1,986 $262,000
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $2,003 - $2,180
-20 Reduced 0.89%
2,235 $243,000
Q3 2023

Nov 09, 2023

BUY
$102.95 - $114.33 $10,295 - $11,433
100 Added 4.64%
2,255 $232,000
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $19,658 - $21,426
181 Added 9.17%
2,155 $248,000
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $37,058 - $41,349
-360 Reduced 15.42%
1,974 $210,000
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $30,604 - $39,238
-350 Reduced 13.04%
2,334 $259,000
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $16,906 - $18,992
200 Added 8.05%
2,684 $231,000
Q2 2022

Aug 10, 2022

SELL
$83.49 - $94.64 $7,931 - $8,990
-95 Reduced 3.68%
2,484 $226,000
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $189,582 - $212,509
2,579 New
2,579 $212,000
Q1 2021

May 12, 2021

SELL
$68.86 - $81.11 $172,907 - $203,667
-2,511 Closed
0 $0
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $183,754 - $208,287
2,511 New
2,511 $208,000
Q1 2020

May 07, 2020

SELL
$63.36 - $87.82 $159,096 - $220,516
-2,511 Closed
0 $0
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $194,803 - $219,812
2,511 New
2,511 $228,000
Q4 2017

Feb 09, 2018

SELL
$51.62 - $61.64 $193,265 - $230,780
-3,744 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$58.67 - $63.13 $219,660 - $236,358
3,744
3,744 $240,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rock Point Advisors, LLC Portfolio

Follow Rock Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rock Point Advisors, LLC with notifications on news.